000 | 05457cam a2200445 i 4500 | ||
---|---|---|---|
001 | ocn907237821 | ||
003 | OCoLC | ||
005 | 20240726105254.0 | ||
008 | 150413s2015 nyu ob 001 0 eng d | ||
040 |
_aNT _beng _erda _epn _cNT _dNT _dIDEBK _dE7B _dYDXCP _dOCLCF _dNLGGC _dEBLCP _dVLB _dAGLDB _dICA _dDEBSZ _dMOR _dCCO _dPIFAG _dVGM _dOCLCO _dZCU _dXFH _dOCLCQ _dMERUC _dOCLCO _dOCLCQ _dOCLCO _dOCLCA _dU3W _dOCLCA _dD6H _dOCLCO _dSTF _dVNS _dOCLCO _dVTS _dOCLCO _dOSU _dICG _dOCLCO _dYDX _dOCLCO _dVT2 _dAU@ _dOCLCO _dOCLCQ _dOCLCA _dWYU _dS9I _dOCLCO _dTKN _dOCLCO _dOCLCA _dOCLCQ _dOCLCO _dDKC _dOCLCO _dOCLCQ _dOCLCO _dUX1 _dOCLCO _dOCLCQ _dOCLCA _dUKAHL _dOCLCA _dOCLCQ _dOCLCO |
||
020 |
_a9780826122797 _q((electronic)l(electronic)ctronic) |
||
050 | 0 | 4 |
_aRC454 _b.N487 2015 |
049 | _aMAIN | ||
100 | 1 |
_aLittrell, Jill, _e1 |
|
245 | 1 | 0 |
_aNeuroscience for psychologists and other mental health professionals : _bpromoting well-being and treating mental illness / _cJill Littrell. |
260 |
_aNew York, NY : _bSpringer Publishing Company, LLC, _c(c)2015. |
||
300 | _a1 online resource | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_adata file _2rda |
||
504 | _a2 | ||
520 | 0 | _aThis book presents the latest neuroscience and physiological explanations behind the major diagnostic categories of mental illness-including schizophrenia, depression, anxiety, and addiction-and explains the physiological bases that underlie traditional pharmaceutical treatment interventions. Crucially, it integrates current information about brain function with new research on immunology, offering a research-based rationale for viewing the mind and the body as an integrated system. The new information on the physiological bases for behavior explains how lifestyle interventions related to die. | |
505 | 0 | 0 | _aCover; Title; Copyright; Contents; Preface; Share Neuroscience for Psychologists and Other Mental Health Professionals: Promoting Well-Being and Treating Mental Illness; Chapter 1: Ways of Thinking About Behavioral Syndromes; The Current Paradigm and How We Got There; History of the Diagnostic and Statistical Manuals of the American Psychiatric Association; Major Depression and Anxiety Used to Be Neurosis; The DSM-IV Continues the Tradition of Medicalizing More of Us; Controversy over the DSM-5; The Limitations of Current Diagnostic Categories; Abandonment of the DSM-5. |
505 | 0 | 0 | _aExtensive Nature of the Mind-Body ConnectionAre Diagnoses Needed?; What Should Be the Criteria for Disorder?; Has Labeling Ordinary Behavior as Mental Illness Resulted in Better Outcomes?; The Approach in This Book; Chapter 2: Physiology; Section 1: Genes and Epigenetics; The Two-Step Process of Making a Protein; How the Cell Decides Whether to Make a Protein; Epigenetics; Telomeres; Section 2: Neurons and Neurotransmitters; The Life Cycle of a Neurotransmitter; How Are the Functions of Neurotransmitters Investigated?; Specific Neurotransmitters; Section 3: The Immune System. |
505 | 0 | 0 | _aTwo Major Divisions: Innate and Adaptive ImmunityThe Glial Cells; Section 4: Circuits; Appetitive Signaling; Creating Learned Helplessness; Regulation of Impulses, Motor Activity, and Emotions; Putting It All Together: BAS and BIS; Section 5: Emotions; Emotions in General; Autonomic Nervous System; Hormonal Activity; Specific Emotions; Section 6: the Human Brain Is Social; Exercises to Rehearse the Vocabulary Used in Subsequent Chapters; Chapter 3: Psychopharmacology; Pharmacokinetics and Pharmacodynamics; Ways to Ingest Drugs; Ways in Which Drugs Are Eliminated from the Body; Drug Dependence. |
505 | 0 | 0 | _aGeneral ConceptsMajor Classes of Psychotropic Drugs; Stimulants; Antipsychotics; Antidepressants; Sedative-Hypnotic Agents; Mood Stabilizers; Major Classes of Drugs of Abuse; Marijuana; Opioids; Nicotine; Alcohol; Marketing of Drugs in the United States; Concerns About Threats to Health; Concerns Over Cost; Where Does the Pharmaceutical Industry Spend Its Money?; Mechanisms for Controlling Medical Practice; Psychiatric Medications; The Role of Behavioral Health Clinicians With Regard to Pharmaceuticals; Obligations in Assuming Responsibilities for Monitoring Side Effects. |
505 | 0 | 0 | _aClinicians Functioning IndependentlyInformed-Consent Duties of Clinicians in Clear Mental Health Professional Roles; What Can Nonmedical Clinicians Say About Medications?; Websites for Information Regarding Drugs; Chapter 4: Depression; The Syndrome of Depressive Behaviors; Prevalence Over Time and Cultures; Findings in Those With Major Depression; Brain Imaging and EEG Findings; Hormonal Findings; Thinking Styles; Emotional Control or Regulation; Brain-Derived Neurotrophic Factor; Theories; Learned Helplessness; Inflammation; Heritability; Drug Treatment; Efficacy; Withdrawal; Side Effects. |
530 |
_a2 _ub |
||
650 | 0 |
_aMental illness _xPathophysiology. |
|
650 | 0 | _aPsychology, Pathological. | |
650 | 0 |
_aBrain _xPathophysiology. |
|
650 | 0 |
_aMental illness _xTreatment. |
|
650 | 0 | _aPsychophysiology. | |
655 | 1 | _aElectronic Books. | |
856 | 4 | 0 |
_uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=977025&site=eds-live&custid=s3260518 _zClick to access digital title | log in using your CIU ID number and my.ciu.edu password |
942 |
_cOB _D _eEB _hRC. _m2015 _QOL _R _x _8NFIC _2LOC |
||
994 |
_a92 _bNT |
||
999 |
_c94832 _d94832 |
||
902 |
_a1 _bCynthia Snell _c1 _dCynthia Snell |